2 results match your criteria Acta scientific cancer biology[Journal]

  • Page 1 of 1

Zinc: The Wonder Drug for the Treatment of Carcinomas.

Acta Sci Cancer Biol 2020 May 27;4(5):33-39. Epub 2020 Apr 27.

Department of Oncology and the Greenebaum Comprehensive Cancer Center, The University of Maryland School of Dentistry, Baltimore, Maryland, USA.

Evidence is evolving that support the relationship that all carcinomas exhibit the following important relationships: The malignant cells exhibit a significant decreased zinc compared to the normal cells. The higher zinc levels that exist in the normal cells are cytotoxic in the malignant cells. The decrease in zinc is due to the down regulation of the ZIP-family zinc uptake transporter. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.31080/ascb.2020.04.0223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316362PMC

Energy Dispersive X-Ray Fluorescence Zn/Fe Ratiometric Determination of Zinc Levels in Expressed Prostatic Fluid: A Direct, Non-Invasive and Highly Accurate Screening for Prostate Cancer.

Acta Sci Cancer Biol 2018 Nov 10;2(9):20-26. Epub 2018 Oct 10.

The Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, Maryland, United States of America.

Prostate specific antigen (PSA) does not provide the reliability that is required for the accurate urology screening of prostate cancer (PCa). Consequently, there has been a major focus and search for a simple, rapid, direct, preferably non-invasive, and highly accurate biomarker and procedure for the urology screening for prostate cancer. Virtually all PCa cases exhibit a marked decrease in zinc in prostate tissue and in prostatic fluid. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289197PMC
November 2018
5 Reads
  • Page 1 of 1